JUSTIN COX: Open Payments
NPI 1184293813 · TOOELE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 46 payments from 15 companies in 2025. Trend: 2023 $739 · 2024 $903 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $166 |
| Novo Nordisk Inc | 5 | $97 |
| ABBVIE INC. | 4 | $85 |
| PFIZER INC. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Lilly USA, LLC | 2 | $38 |
| Verity Pharmaceuticals Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
Products named: OTEZLA, NURTEC ODT, Wegovy, EVENITY, VRAYLAR, QULIPTA, MOUNJARO, Tlando.
Industry payments across UT — which companies pay providers there.
